|
CAE |
PAE |
OGE |
NEA |
p-value |
Number |
28 |
18 |
11 |
23 |
|
Male (%) |
24 (85.7%) |
9 (50%) |
7 (63.6%) |
10 (43.5%) |
0.02 |
Age (Years)
|
1
(1-2.25)
|
3
(2-4.5)
|
2
(1.5-3.5)
|
3
(1-4)
|
n.s.
|
AD (%) |
18 (64.3%) |
12 (66.7%) |
7 (63.6%) |
11 (47.8%) |
n.s. |
Family AD (%) |
17 (60.7%) |
12 (66.7%) |
4 (36.4%) |
7 (30.4%) |
0.0127 |
WBC (/µL)
|
11,200
(8,300-14,800)
|
7,350
(6,300-8,925)
|
8,500
(7,100-9,800)
|
8,600
(7,500-11,300)
|
n.s.
|
Eo (%)
|
3
(2-4.2)
|
3
(1.9-4.3)
|
2
(1.3-4)
|
2
(1-3)
|
n.s.
|
Plt (X104/µL)
|
34.7
(30.6-43.4)
|
29.2
(27.0-35.4)
|
35.4
(29.1-38.1)
|
33.7
(26.7-35.7)
|
n.s.
|
Total IgE
(IU/mL)
|
158
(47.5-522.5)
|
140.5
(50.8-452.3)
|
60.5
(48-440)
|
22.3
(8.7-110.7)
|
n.s.
|
EW-sIgE
(UA/mL)
|
18.6
(2.9-35.5)
|
2.0
(1.1-6.2)
|
1.48
(0.98-2.59)
|
0.9
(0.3-1.4)
|
<0.0001
|
OVM-sIgE
(UA/mL)
|
3.30
(1.2-10.3)
|
1.48
(0.5-2.1)
|
0.48
(0.3-1.1)
|
0.36
(0.26-1.11)
|
n.s.
|